5 insiders reported 11 Form 4 transactions for Hepion Pharmaceuticals, Inc. (HEPA) over the past 18 months (most recent 2026-08-12). Recent activity: Stetz Gary S. (Interim CEO) Buy 2.0M shares, LoPriore Vincent S (Executive Chairman) Buy 8.0M shares, Purcell Michael J. (Director) Buy 2.0M shares, Appajosyula Sireesh (Chief Operating Officer) Buy 2.0M shares, Stetz Gary S. II (Director) Buy 500,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Stetz Gary S. | Interim CEO | Buy | 2.0M | $100,000 |
| 2026-08-12 | LoPriore Vincent S | Executive Chairman | Buy | 8.0M | $400,000 |
| 2026-08-12 | Purcell Michael J. | Director | Buy | 2.0M | $100,000 |
| 2026-08-12 | Appajosyula Sireesh | Chief Operating Officer | Buy | 2.0M | $100,000 |
| 2026-08-12 | Stetz Gary S. II | Director | Buy | 500,000 | $25,000 |
| 2026-08-12 | LoPriore Vincent S | Executive Chairman | Buy | 2.0M | $100,000 |
| 2026-04-27 | Stetz Gary S. | Interim CEO | Buy | 1.2M | $50,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | Buy | 5.0M | $200,000 |
| 2026-04-27 | Purcell Michael J. | Director | Buy | 1.2M | $50,000 |
| 2026-04-27 | Appajosyula Sireesh | Director | Buy | 1.2M | $50,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | Buy | 1.2M | $50,000 |
Source: SEC Form 4 filings · as of 2026-08-12